Drug Cuts Prostate Cancer Rate, Study Finds

  • Playlist
  • Download
  • Embed
    <iframe src="" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

Researchers halt a federally financed study of the prostate-shrinking drug finasteride 15 months early, saying results so far prove the drug can also reduce a man's chance of developing prostate cancer by 25 percent. But the study also found that men who develop the disease while taking the drug have a higher chance of getting more aggressive tumors. NPR's Richard Knox reports.



Please keep your community civil. All comments must follow the Community rules and terms of use, and will be moderated prior to posting. NPR reserves the right to use the comments we receive, in whole or in part, and to use the commenter's name and location, in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

NPR thanks our sponsors

Become an NPR sponsor

Support comes from